Intriguingly, treatment with compound C (an AMPK inhibitor) or AMPK1α siRNA significantly inhibited SIRT3 expression, suggesting that celastrol attenuates liver fibrosis primarily by activating the AMPK-SIRT3 signaling pathway to inhibit inflammation [130]. The gene discussed is SIRT3; the disease is Hepatic fibrosis.